The All India Institute of Medical Sciences in Delhi has started screening children aged between 12-18 years for clinical trials of India's indigenous COVID-19 vaccine- Bharat Biotech's Covaxin.
Haryana Chief Minister Manohar Lal Khattar announced that the state will be creating an 'Oxi-van' spanning 80 acres in the Karnal district for people to visit.
India's rank has slipped by two places from last year to 117 on the 17 Sustainable Development Goals adopted as a part of the 2030 agenda by 193 United Nations member states in 2015.
The Delhi government ordered all private hospitals and nursing homes to ensure that the Covaxin doses are used only to vaccinate those people from the 18-44 age group who are eligible for receiving the second dose in June.